TransMedics (TMDX) Change in Accured Expenses (2018 - 2026)

TransMedics' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$3.1 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 33.14% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was $19.2 million, a 475.32% increase from a year earlier, with the FY2025 full-year figure at $17.7 million, up 122.9% from the prior year.
• Change in Accured Expenses eased to -$3.1 million in Q1 2026 per TMDX's latest filing, from $7.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $13.1 million in Q3 2025 and bottomed at -$4.6 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is $2.2 million (2025), against an average of $2.4 million.
• Across the five-year window, Change in Accured Expenses surged 86450.0% in 2023 and slumped 9377.55% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $3.4 million in 2022, then surged by 44.93% to $5.0 million in 2023, then plunged by 53.45% to $2.3 million in 2024, then surged by 199.74% to $7.0 million in 2025, then plunged by 144.57% to -$3.1 million in 2026.
• Per Business Quant, the three latest TMDX Change in Accured Expenses figures stand at -$3.1 million (Q1 2026), $7.0 million (Q4 2025), and $13.1 million (Q3 2025).